Liver Transplantation — Written Clinical Reasoning · Phys Written Answers

Prompt

DCE-style written reasoning for Liver Transplantation.

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Liver Transplantation and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Ma Z, Niu Z, Yu A, Guo Y, et al. Severe hepatotoxicity associated with orlistat: clinical presentation, risk factors and outcomes Front Pharmacol, 2026.PMID 42465996
[2]Tapia-Villacis S, Prieto J, López M, Medina J Disseminated Phaeohyphomycosis Due to Alternaria alternata in a Liver Transplant Recipient: Successful Treatment With Isavuconazole, a Case Report and Literature Review Case Rep Transplant, 2026.PMID 42465679
[3]Lee H, Jung KU, Luu M, Kosari K, et al. Perioperative mortality and survival after lymph node excision in hepatocellular carcinoma: a national cancer database propensity score-matched cohort study World J Surg Oncol, 2026.PMID 42464368
[4]Morales Junior R, Telles JP, Chua NGS, Kunicki PK, et al. Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024) Ther Drug Monit, 2026.PMID 42457203
[5]You H, Maiwall R, Chen J, Ahn SH, et al. APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update Hepatol Int, 2026.PMID 42365189
[6]Perito ER, Chen JK, Danziger-Isakov LA, Desai MS, et al. AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Post-transplant management Liver Transpl, 2026.PMID 42329162
[7]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
[8]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Liver Transplantation and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Ma Z, Niu Z, Yu A, Guo Y, et al. Severe hepatotoxicity associated with orlistat: clinical presentation, risk factors and outcomes Front Pharmacol, 2026.PMID 42465996
[2]Tapia-Villacis S, Prieto J, López M, Medina J Disseminated Phaeohyphomycosis Due to Alternaria alternata in a Liver Transplant Recipient: Successful Treatment With Isavuconazole, a Case Report and Literature Review Case Rep Transplant, 2026.PMID 42465679
[3]Lee H, Jung KU, Luu M, Kosari K, et al. Perioperative mortality and survival after lymph node excision in hepatocellular carcinoma: a national cancer database propensity score-matched cohort study World J Surg Oncol, 2026.PMID 42464368
[4]Morales Junior R, Telles JP, Chua NGS, Kunicki PK, et al. Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024) Ther Drug Monit, 2026.PMID 42457203
[5]You H, Maiwall R, Chen J, Ahn SH, et al. APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update Hepatol Int, 2026.PMID 42365189
[6]Perito ER, Chen JK, Danziger-Isakov LA, Desai MS, et al. AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Post-transplant management Liver Transpl, 2026.PMID 42329162
[7]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
[8]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005